Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models
Crossref DOI link: https://doi.org/10.1186/1756-9966-33-52
Published Online: 2014-06-17
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qu, Yiqing
Wu, Xiuxiu
Yin, Yunhong
Yang, Yan
Ma, Dedong
Li, Hao
Article History
Received: 23 May 2014
Accepted: 2 June 2014
First Online: 17 June 2014